levamisole has been researched along with Toxoplasmosis in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (60.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Abo Safia, HS; El Maghraby, GM; Elmansory, BM; Eltokhy, AK; Issa, YA; Salama, AM; Zoghroban, HS | 1 |
Bilgin, K; Hokelek, M; Köksal, ZŞ; Yanik, K; Yılmaz, EM | 1 |
Lebedev, KA; Moroz, BV; Nikiforov, VN; Noeva, NA | 1 |
Fegies, M; Guerrero, J | 1 |
Arafa, MS; el-Ridi, AM; el-Sawy, MF; el-Sayed, WM; Youssef, MY | 1 |
5 other study(ies) available for levamisole and Toxoplasmosis
Article | Year |
---|---|
Novel insights on the therapeutic effect of levamisole on the chronic toxoplasmosis in mice model.
Topics: Animals; Humans; Levamisole; Mice; Spiramycin; Toxoplasma; Toxoplasmosis | 2023 |
In Vivo Efficacy of Drugs against Toxoplasma gondii Combined with Immunomodulators.
Topics: Administration, Oral; Animals; Antiprotozoal Agents; Disease Models, Animal; Drug Therapy, Combination; Female; Immunologic Factors; Levamisole; Mice, Inbred BALB C; Pyrimethamine; Sulfadiazine; Survival Analysis; Toxoplasma; Toxoplasmosis; Treatment Outcome | 2016 |
[Use of levamisole (decaris) for treating chronic acquired toxoplasmosis].
Topics: Adolescent; Adult; B-Lymphocytes; Chronic Disease; Drug Evaluation; Female; Humans; Levamisole; Male; Middle Aged; Pyrimethamine; Sulfadimethoxine; T-Lymphocytes; Time Factors; Toxoplasmosis | 1981 |
Treatment of toxoplasmosis with levamisole.
Topics: Humans; Levamisole; Sulfamethoxazole; T-Lymphocytes; Toxoplasmosis | 1977 |
Effect of levamisole on toxoplasmosis during pregnancy in guinea-pigs.
Topics: Animals; Dose-Response Relationship, Drug; Female; Guinea Pigs; Levamisole; Pregnancy; Pregnancy Complications, Infectious; Toxoplasmosis | 1985 |